| 摘要 |
The invention relates to the use of anastrozole and vitamin D analogues in combined therapy of breast cancer. Vitamin D analogues are selected from a group including calcipotriol, tacalcitol and (1S,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-secochola- 5,7,10(19),22-tetraen-l,3,24-triol (isomer 5,6-trans of calcipotriol). |
